Sushama Talegaonkar
Sushama Talegaonkar
Delhi Pharmaceutical Sciences and Research University, New Delhi
Verified email at
Cited by
Cited by
Development and bioavailability assessment of ramipril nanoemulsion formulation
S Shafiq, F Shakeel, S Talegaonkar, FJ Ahmad, RK Khar, M Ali
European journal of pharmaceutics and biopharmaceutics 66 (2), 227-243, 2007
Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimisation and in vitro characterisation
SK Motwani, S Chopra, S Talegaonkar, K Kohli, FJ Ahmad, RK Khar
European Journal of Pharmaceutics and Biopharmaceutics 68 (3), 513-525, 2008
Zinc oxide nanoparticles: a promising nanomaterial for biomedical applications
PK Mishra, H Mishra, A Ekielski, S Talegaonkar, B Vaidya
Drug discovery today 22 (12), 1825-1834, 2017
Nanoemulsion components screening and selection: a technical note
A Azeem, M Rizwan, FJ Ahmad, Z Iqbal, RK Khar, M Aqil, S Talegaonkar
Aaps Pharmscitech 10, 69-76, 2009
Microemulsions: a novel approach to enhanced drug delivery
S Talegaonkar, A Azeem, FJ Ahmad, RK Khar, SA Pathan, ZI Khan
Recent patents on drug delivery & formulation 2 (3), 238-257, 2008
Formulation development and optimization using nanoemulsion technique: a technical note
S Shafiq-un-Nabi, F Shakeel, S Talegaonkar, J Ali, S Baboota, A Ahuja, ...
AAPS pharmscitech 8, E12-E17, 2007
Vesicular systems: an overview
S Biju, S Talegaonkar, P Mishra, R Khar
Indian journal of pharmaceutical sciences 68 (2), 2006
Ceramic nanoparticles: fabrication methods and applications in drug delivery
S C Thomas, P Kumar Mishra, S Talegaonkar
Current pharmaceutical design 21 (42), 6165-6188, 2015
Recent approaches for the treatment of periodontitis
N Jain, GK Jain, S Javed, Z Iqbal, S Talegaonkar, FJ Ahmad, RK Khar
Drug discovery today 13 (21-22), 932-943, 2008
Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy
T Bansal, M Jaggi, R Khar, S Talegaonkar
Journal of pharmacy & pharmaceutical sciences 12 (1), 46-78, 2009
Metal nanoparticles: a theranostic nanotool against cancer
H Sharma, PK Mishra, S Talegaonkar, B Vaidya
Drug discovery today 20 (9), 1143-1151, 2015
Intranasal delivery: An approach to bypass the blood brain barrier
S Talegaonkar, PR Mishra
Indian journal of pharmacology 36 (3), 140-147, 2004
CNS drug delivery systems: novel approaches
SA Pathan, Z Iqbal, S Zaidi, S Talegaonkar, D Vohra, GK Jain, A Azeem, ...
Recent patents on drug delivery & formulation 3 (1), 71-89, 2009
Multiple emulsions: an overview
A Yaqoob Khan, S Talegaonkar, Z Iqbal, F Jalees Ahmed, R Krishan Khar
Current drug delivery 3 (4), 429-443, 2006
Microemulsions as a surrogate carrier for dermal drug delivery
A Azeem, ZI Khan, M Aqil, FJ Ahmad, RK Khar, S Talegaonkar
Drug development and industrial pharmacy 35 (5), 525-547, 2009
Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation
T Bansal, N Akhtar, M Jaggi, RK Khar, S Talegaonkar
Drug discovery today 14 (21-22), 1067-1074, 2009
Niosomes in sustained and targeted drug delivery: some recent advances
A Azeem, MK Anwer, S Talegaonkar
Journal of drug targeting 17 (9), 671-689, 2009
Melanoma treatment: from conventional to nanotechnology
H Mishra, PK Mishra, A Ekielski, M Jaggi, Z Iqbal, S Talegaonkar
Journal of cancer research and clinical oncology 144, 2283-2302, 2018
Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery
S Chopra, S Mahdi, J Kaur, Z Iqbal, S Talegaonkar, FJ Ahmad
Journal of Pharmacy and Pharmacology 58 (8), 1021-1032, 2006
Cellulose nanofiber aerogel as a promising biomaterial for customized oral drug delivery
J Bhandari, H Mishra, PK Mishra, R Wimmer, FJ Ahmad, S Talegaonkar
International journal of nanomedicine, 2021-2031, 2017
The system can't perform the operation now. Try again later.
Articles 1–20